HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mary Cabiddu Selected Research
Mary Cabiddu Research Topics
Disease
22
Neoplasms (Cancer)
11/2022 - 12/2008
17
Breast Neoplasms (Breast Cancer)
01/2022 - 04/2008
11
Colorectal Neoplasms (Colorectal Cancer)
12/2019 - 07/2011
10
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 09/2003
7
Lung Neoplasms (Lung Cancer)
11/2022 - 10/2005
6
Pathologic Complete Response
02/2024 - 02/2014
5
Anemia
04/2019 - 01/2012
5
Pancreatic Neoplasms (Pancreatic Cancer)
04/2019 - 01/2010
4
Brain Neoplasms (Brain Tumor)
02/2020 - 10/2017
4
Melanoma (Melanoma, Malignant)
01/2019 - 07/2015
3
Triple Negative Breast Neoplasms
02/2024 - 04/2014
3
Infections
01/2023 - 01/2022
3
Nausea
04/2019 - 06/2012
3
Diarrhea
04/2019 - 05/2012
3
Neoplasm Metastasis (Metastasis)
12/2018 - 11/2010
3
Cardiotoxicity
06/2016 - 02/2011
2
COVID-19
01/2023 - 01/2022
2
Ovarian Neoplasms (Ovarian Cancer)
06/2020 - 07/2011
2
Rectal Neoplasms (Rectal Cancer)
01/2020 - 02/2017
2
Neutropenia
04/2019 - 11/2018
2
Adenocarcinoma
01/2018 - 03/2012
2
Renal Cell Carcinoma (Grawitz Tumor)
12/2016 - 07/2015
2
Vomiting
06/2016 - 06/2012
2
Carcinoma (Carcinomatosis)
07/2015 - 03/2012
2
Exanthema (Rash)
10/2012 - 05/2012
1
Venous Thromboembolism
01/2022
1
Febrile Neutropenia
04/2019
1
Margins of Excision
01/2019
1
Merkel Cell Carcinoma
01/2019
1
Thrombocytopenia (Thrombopenia)
11/2018
1
Mesothelioma
01/2018
1
Malignant Mesothelioma
01/2018
Drug/Important Bio-Agent (IBA)
8
Bevacizumab (Avastin)
FDA Link
04/2015 - 12/2008
5
Fluorouracil (Carac)
FDA Link
Generic
01/2021 - 06/2012
5
Platinum
IBA
06/2020 - 10/2009
5
ErbB Receptors (EGF Receptor)
IBA
01/2018 - 07/2011
5
Biomarkers (Surrogate Marker)
IBA
02/2017 - 01/2013
5
Cetuximab (Erbitux)
FDA Link
03/2015 - 07/2011
5
Erlotinib Hydrochloride (CP 358,774)
FDA Link
10/2012 - 11/2011
4
Capecitabine (Xeloda)
FDA Link
01/2021 - 06/2012
4
Oxaliplatin (Eloxatin)
FDA Link
Generic
04/2019 - 03/2013
4
Irinotecan (Camptosar)
FDA Link
Generic
04/2019 - 03/2013
4
Gemcitabine
FDA Link
04/2019 - 01/2010
4
Cisplatin (Platino)
FDA Link
Generic
11/2014 - 01/2013
4
Tyrosine Kinase Inhibitors
IBA
10/2012 - 11/2011
3
taxane
IBA
02/2024 - 09/2012
3
Anthracyclines
IBA
02/2024 - 02/2011
3
ribociclib
IBA
01/2022 - 04/2019
3
abemaciclib
IBA
01/2022 - 04/2019
3
palbociclib
IBA
01/2022 - 04/2019
3
Estrogen Receptors
IBA
01/2020 - 02/2010
3
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
01/2019 - 02/2015
3
Pemetrexed (MTA)
FDA Link
01/2018 - 10/2012
3
Docetaxel (Taxotere)
FDA Link
06/2015 - 10/2012
3
Panitumumab (Vectibix)
FDA Link
03/2015 - 07/2011
3
Gefitinib (Iressa)
FDA Link
10/2012 - 01/2012
3
Monoclonal Antibodies
IBA
05/2012 - 12/2008
2
Aromatase Inhibitors
IBA
01/2022 - 01/2020
2
Hormones (Hormone)
IBA
01/2022 - 06/2015
2
eribulin
FDA Link
01/2020 - 01/2015
2
Immune Checkpoint Inhibitors
IBA
01/2020 - 06/2016
2
folfirinox
IBA
04/2019 - 05/2015
2
Hematinics
IBA
01/2013 - 02/2012
2
Trastuzumab (Herceptin)
FDA Link
02/2011 - 04/2008
1
Cholecalciferol (Vitamin D3)
FDA Link
01/2023
1
Immunoglobulin G (IgG)
IBA
01/2022
1
osimertinib
IBA
01/2022
1
Fulvestrant (Faslodex)
FDA Link
01/2022
1
Capsules (Microcapsules)
IBA
06/2020
1
olaparib
IBA
06/2020
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
06/2020
1
Tablets
IBA
06/2020
1
Steroids
IBA
02/2020
1
Tamoxifen
FDA Link
Generic
01/2020
1
2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamide
IBA
01/2020
1
TOR Serine-Threonine Kinases
IBA
01/2020
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2020
1
Trinitrotoluene (TNT)
IBA
01/2020
1
Cyclin-Dependent Kinase 4
IBA
01/2020
1
Everolimus
FDA Link
01/2020
1
Proteins (Proteins, Gene)
FDA Link
12/2019
1
Calcibiotic Root Canal Sealer
IBA
12/2019
1
Anti-Bacterial Agents (Antibiotics)
IBA
08/2019
1
130-nm albumin-bound paclitaxel
IBA
04/2019
1
avelumab
IBA
11/2018
1
Anaplastic Lymphoma Kinase
IBA
01/2018
1
B7-H1 Antigen
IBA
01/2018
1
Lapatinib (GW572016)
FDA Link
10/2017
1
Cytokines
IBA
12/2016
Therapy/Procedure
27
Drug Therapy (Chemotherapy)
02/2024 - 09/2003
25
Therapeutics
01/2022 - 04/2008
10
Neoadjuvant Therapy
02/2024 - 11/2010
4
Radiotherapy
12/2019 - 11/2014
3
Adjuvant Chemotherapy
01/2021 - 02/2010
3
Immunotherapy
12/2019 - 11/2018
2
Adjuvant Radiotherapy
01/2019 - 10/2015
2
Combination Drug Therapy (Combination Chemotherapy)
05/2014 - 10/2009
1
Artificial Respiration (Mechanical Ventilation)
11/2022
1
Erythrocyte Transfusion
10/2021
1
Induction Chemotherapy
01/2020